How health care systems and providers can address cisnormativity

Video

Halley Crissman, MD, MPH, shares her insight on the ways in which hospital systems reinforce cisnormativity and focal points to address for a more welcoming environment.

In a recent interview with Contemporary OB/GYN, Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, discuss cisnormativity and the damage it can have on patient care.

Cisgender (adj): People whose gender identity and/or gender expression aligns with the gender typically associated with their sex assigned at birth.

Cisnormativity (n): The assumption that all individuals are cisgender and the ways the social world is constructed to address the needs of cisgender people and to encourage conformity with such norms.

Read the full, peer-reviewed article from Drs. Crissman and Stroumsa now: Gynecologic care considerations for transmasculine people

__

Related: Terminology for ob/gyns to use when treating transgender patients

Recent Videos
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
Ipek Ensari, PhD, highlights improved mental health in chronic pelvic pain from physical activity | Image Credit: scholars.mssm.edu
Evaluating a miniature robotic device for hysterectomy | Image Credit: linkedin.com.
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Lauren Streicher, MD
Learning what women prefer in STI preventive care
Why doxycycline PEP lacks clinical data for STI prevention in women
Related Content
Contemporary OB/GYN week in review: Menstrual symptoms, cognitive decline, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Menstrual symptoms, cognitive decline, and more

Celeste Krewson, Assistant Editor
April 18th 2025
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Testing protocols and general prevalence of STIs during COVID-19

Testing protocols and general prevalence of STIs during COVID-19

April 16th 2021
Podcast

April is STI Awareness Month, and as such, we are focusing on testing and increase of STDs in the pandemic, especially how women and minorities are affected.

Listen

Menstrual cycle phase linked to inflammation in women with sickle cell disease | Image Credit: © 9nong - © 9nong - stock.adobe.com.

Menstrual cycle phase linked to inflammation in women with sickle cell disease

Celeste Krewson, Assistant Editor
April 14th 2025
Article

New research reveals elevated C-reactive protein levels during the follicular phase of menstruation may explain pain crisis patterns in female sickle cell patients.

Read More

S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH

S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH

Lindsey Carr, Editor
February 19th 2021
Podcast

On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.

Listen

Contemporary OB/GYN week in review: Gepotidacin approval, placebo efficacy, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Gepotidacin approval, placebo efficacy, and more

Celeste Krewson, Assistant Editor
March 28th 2025
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Placebo pills found to significantly reduce premenstrual syndrome symptoms | Image Credit: © Farknot Architect - © Farknot Architect - stock.adobe.com.

Placebo pills found to significantly reduce premenstrual syndrome symptoms

Celeste Krewson, Assistant Editor
March 27th 2025
Article

A new study found that open-label placebos can effectively reduce the intensity and interference of premenstrual syndrome symptoms, even when patients know they are taking a placebo.

Read More

© 2025 MJH Life Sciences

All rights reserved.